Bruker Corporation vs. EyePoint, Inc. Common Stock
Bruker Corporation (BRKR) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BRKR | EYPT | |
|---|---|---|
| Market Cap | $8.79 billion | $1.27 billion |
| Revenue (TTM) | $3.50 billion | $2.79 million |
| Net Income (TTM) | $-64,500,000 | $-306,643,000 |
BRKR leads on 3 of 3 size & scale factors.
Valuation
| BRKR | EYPT | |
|---|---|---|
| Price / Book | 3.66 | 7.64 |
| Price / Sales | 2.51 | 455.94 |
BRKR leads on 2 of 2 valuation factors.
Profitability
| BRKR | EYPT | |
|---|---|---|
| Net Margin | -1.84% | -10994.73% |
| Return on Equity | -2.69% | -184.27% |
BRKR leads on 2 of 2 profitability factors.
Dividend
| BRKR | EYPT | |
|---|---|---|
| Dividend Yield | 0.35% | — |
BRKR and EYPT split the dividend factors evenly.
Risk & Sentiment
| BRKR | EYPT | |
|---|---|---|
| Short Interest | 1.53% | 1.22% |
EYPT leads on 1 of 1 risk & sentiment factors.
Dig deeper: BRKR overview, BRKR financials, EYPT overview, EYPT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.